Emission Fourier transform spectroscopy for remote sensingof the Earth's atmosphere

Fourier transform emission spectroscopy can make an important contribution in the observation of the Earth's atmosphere and in the investigation of atmospheric physics and chemistry. In this paper, we report the measurement performances and the result obtained by a Fourier transform spectrometer, named SAFIRE-A (Spectroscopy of the Atmosphere using Far Infrared Emission - Airborne), operating in the far infrared spectral region from limb sounding observation of the atmospheric emission from a high altitude aircraft. After a short review of the advantages of FTS emission limb sounding in comparison with competing techniques and observation geometries, a detailed description of the instrument is given with the result obtained during the APE-GAIA (Airborne Polar Experiment - Geophysica Aircraft In Antarctica) fi eld campaign carried out over the Antarctic Peninsula

Technical Note: Continuity of MIPAS-ENVISAT ozone data quality from full- to reduced-spectral-resolution operation mode

International audienceMIPAS (Michelson Interferometer for Passive Atmospheric Sounding) is operating on the ENVIronmental SATellite (ENVISAT) since March 2002. After two years of nearly continuous limb scanning measurements, at the end of March 2004, the instrument was stopped due to problems with the mirror drive of the interferometer. Operations with reduced maximum path difference, corresponding to both a reduced-spectral-resolution and a shorter measurement time, were resumed on January 2005. In order to exploit the reduction in measurement time, the measurement scenario was changed adopting a finer vertical limb scanning. The change of spectral resolution and of measurement scenario entailed an update of the data processing strategy. The aim of this paper is the assessment of the differences in the quality of the MIPAS ozone data acquired before and after the stop of the operations. Two sets of MIPAS ozone profiles acquired in 2003?2004 (full-resolution measurements) and in 2005?2006 (reduced-resolution measurements) are compared with collocated ozone profiles obtained by GOMOS (Global Ozone Monitoring by Occultation of Stars), itself also onboard ENVISAT. The continuity of the GOMOS data quality allows to assess a possible discontinuity of the MIPAS performances. The relative bias and precision of MIPAS ozone profiles with respect to the GOMOS ones have been compared for the measurements acquired before and after the stop of the MIPAS operations. The results of the comparison show that, in general, the quality of the MIPAS ozone profiles retrieved from reduced-resolution measurements is comparable or better than that obtained from the full-resolution dataset. The only significant change in MIPAS performances is observed at pressures around 2 hPa, where the relative bias of the instruments increases by a factor of 2 from the 2003?2004 to 2005?2006 measurements

Measurement of the water vapour vertical profile and of the Earth's outgoing far infrared flux

International audienceOur understanding of global warming depends on the accuracy with which the atmospheric components that modulate the Earth's radiation budget are known. Many uncertainties still exist on the radiative effect of water in the different spectral regions, among which the far infrared where few observations have been made. An assessment is shown of the atmospheric outgoing flux obtained from a balloon-borne platform with wideband spectrally resolved nadir measurements at the top-of-atmosphere over the full spectral range, including the far infrared, from 100 to 1400 cm?1, made by a Fourier transform spectrometer with uncooled detectors. From these measurements, we retrieve 15 pieces of information about water vapour and temperature profiles, and surface temperature, with a precision of 5% for the mean water vapour profile and a major improvement of the upper troposphere-lower stratosphere knowledge. The retrieved atmospheric state makes it possible to calculate the emitted radiance as a function of the zenith angle and to determine the outgoing radiation flux, proving that spectrally resolved observations can be used to derive accurate information on the integrated flux. While the retrieved temperature is in good agreement with ECMWF analysis, the retrieved water vapour profile differs significantly, and, depending on time and location, the derived flux differs in the far infrared (0?600 cm?1) from that derived from ECMWF by 2?3.5 W/m2±0.4 W/m2. The observed discrepancy is larger than current estimates of radiative forcing due to CO2 increases since pre-industrial time. The error with which the flux is determined is caused mainly by calibration uncertainties while detector noise has a negligible effect, proving that uncooled detectors are adequate for top of the atmosphere radiometry

First spectral measurement of the Earth's upwelling emission using an uncooled wideband Fourier transform spectrometer

International audienceThe first spectral measurement of Earth's emitted radiation to space in the wideband range from 100 to 1400 cm-1 with 0.5 cm-1 spectral resolution is presented. The measurement was performed from a stratospheric balloon in tropical region using a Fourier transform spectrometer, during a field campaign held in Brazil in June 2005. The instrument, which has uncooled components including the detector module, is a prototype developed as part of the study for the REFIR (Radiation Explorer in the Far InfraRed) space mission. This paper shows the results of the field campaign with particular attention to the measurement capabilities of the prototype. The results are compared with measurements taken by IASI-balloon (Infrared Atmospheric Sounding Interferometer – Balloon version), aboard the same platform, and with forward model estimations. The infrared signature of clouds is observed in the measurements

Technical note: First spectral measurement of the Earth's upwelling emission using an uncooled wideband Fourier transform spectrometer

The first spectral measurement of Earth's emitted radiation to space in the wideband range from 100 to 1400 cm^−1 with 0.5 cm^−1 spectral resolution is presented. The measurement was performed from a stratospheric balloon in tropical region using a Fourier transform spectrometer, during a field campaign held in Brazil in June 2005. The instrument, which has uncooled components including the detector module, is a prototype developed as part of the study for the REFIR (Radiation Explorer in the Far InfraRed) space mission. This paper shows the results of the field campaign with particular attention to the measurement capabilities of the prototype. The results are compared with measurements taken by IASI-balloon (Infrared Atmospheric Sounding Interferometer – Balloon version), aboard the same platform, and with forward model estimations. The infrared signature of clouds is observed in the measurements

Technical note: First spectral measurement of the Earth's upwelling emission using an uncooled wideband Fourier transform spectrometer

International audienceThe first spectral measurement of Earth's emitted radiation to space in the wideband range from 100 to 1400 cm-1 with 0.5 cm-1 spectral resolution is presented. The measurement was performed from a stratospheric balloon in tropical region using a Fourier transform spectrometer, during a field campaign held in Brazil in June 2005. The instrument, which has uncooled components including the detector module, is a prototype developed as part of the study for the REFIR (Radiation Explorer in the Far InfraRed) space mission. This paper shows the results of the field campaign with particular attention to the measurement capabilities of the prototype. The results are compared with measurements taken by IASI-balloon (Infrared Atmospheric Sounding Interferometer – Balloon version), aboard the same platform, and with forward model estimations. The infrared signature of clouds is observed in the measurements

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Background: The Italian Renal Cell Cancer Early Access Program was an expanded access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell carcinoma (mRCC) prior to regulatory approval. Methods: Pts with previously treated advanced or mRCC were eligible to receive nivolumab 3 mg/kg every 2 weeks. Pts included in the analysis had received ≥1 dose of nivolumab and were monitored for drug-related adverse events (drAEs) using CTCAE v.4.0. Immune-related (ir) AEs were defined as AEs displaying a certain, likely or possible correlation with immunotherapy (cutaneous, endocrine, hepatic, gastro-intestinal and pulmonary). The association between overall survival (OS) and irAEs was assessed, and associations between variables were evaluated with a logistic regression model. Results: A total of 389 pts were enrolled between July 2015 and April 2016. Overall, the objective response rate was 23.1%. At a median follow-up of 12 months, the median progression-free survival was 4.5 months (95% CI 3.7-6.2) and the 12-month overall survival rate was 63%. Any grade and grade 3-4 drAEs were reported in 124 (32%) and 27 (7%) of pts, respectively, and there were no treatment-related deaths. Any grade irAEs occurred in 76 (20%) of patients, 8% cutaneous, 4% endocrine, 2% hepatic, 5% gastro-intestinal and 1% pulmonary. Of the 22 drAEs inducing treatment discontinuation, 10 (45%) were irAEs. Pts with drAEs had a significantly longer survival than those without drAEs (median OS 22.5 versus 16.4 months, p = 0.01). Pts with irAEs versus without irAEs had a more significant survival benefit (median OS not reached versus 16.8 months, p = 0.002), confirmed at the landmark analysis at 6 weeks. The occurrence of irAEs displayed a strong association with OS in univariable (HR 0.48, p = 0.003) and multivariable (HR 0.57, p = 0.02) analysis. Conclusions: The appearance of irAEs strongly correlates with survival benefit in a real-life population of mRCC pts treated with nivolumab

Validation and data characteristics of methane and nitrous oxide profiles observed by MIPAS and processed with Version 4.61 algorithm

The ENVISAT validation programme for the atmospheric instruments MIPAS, SCIAMACHY and GOMOS is based on a number of balloon-borne, aircraft, satellite and ground-based correlative measurements. In particular the activities of validation scientists were coordinated by ESA within the ENVISAT Stratospheric Aircraft and Balloon Campaign or ESABC. As part of a series of similar papers on other species [this issue] and in parallel to the contribution of the individual validation teams, the present paper provides a synthesis of comparisons performed between MIPAS CH4 and N2O profiles produced by the current ESA operational software (Instrument Processing Facility version 4.61 or IPF v4.61, full resolution MIPAS data covering the period 9 July 2002 to 26 March 2004) and correlative measurements obtained from balloon and aircraft experiments as well as from satellite sensors or from ground-based instruments. In the middle stratosphere, no significant bias is observed between MIPAS and correlative measurements, and MIPAS is providing a very consistent and global picture of the distribution of CH4 and N2O in this region. In average, the MIPAS CH4 values show a small positive bias in the lower stratosphere of about 5%. A similar situation is observed for N2O with a positive bias of 4%. In the lower stratosphere/upper troposphere (UT/LS) the individual used MIPAS data version 4.61 still exhibits some unphysical oscillations in individual CH4 and N2O profiles caused by the processing algorithm (with almost no regularization). Taking these problems into account, the MIPAS CH4 and N2O profiles are behaving as expected from the internal error estimation of IPF v4.61 and the estimated errors of the correlative measurements

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

High-dose interleukin-2 (HD IL-2) has curative potential in metastatic melanoma (MM) and renal cell carcinoma (RCC). Radiotherapy (RT) kills cancer cells and induces immunomodulatory effects. Prospective trials exploring clinical and immunological properties of combined RT/HD IL-2 are still needed. We designed a phase II, single-arm clinical trial for patients with MM and RCC. The treatment schedule consisted of 3 daily doses of 6-12 Gy of RT to 1-5 non-index metastatic fields, before IL-2 at the first and third treatment cycle. HD IL-2 was administered by continuous infusion for 72 hours and repeated every 3 weeks for up to 4 cycles, thereafter every 4 weeks for a maximum of 2 cycles. The primary endpoint was the immunological efficacy of the combined RT/HD IL-2 treatment (assessed by IFN-γ ELISPOT). Nineteen out of 22 patients were evaluable for immunological and clinical response. Partial response occurred in 3 (15.7%) patients and stable disease was observed in 7 (36.8%). The disease control rate was 52.6% after a median follow up of 39.2 months. According to Common Terminology Criteria for Adverse Events 4.0 (CTCAE 4.0), the majority of toxicities were grade 1-2. Immunological responses were frequent and detected in 16 (84.2%) patients. Increased levels of IL-8 and IL-10 in melanoma, circulating effector memory CD4+ and intratumoral CD8+ T cells in both tumor types were detected after therapy. Overall the treatment was well tolerated and immunologically active. Immunomonitoring and correlative data on tumor and peripheral blood cell subsets suggest that this combination treatment could be a promising strategy for patients progressing after standard treatments